Mayne Pharma Group Ltd: Mayne Pharma to present at HC Wainwright conference in NY
Mayne Pharma Group Ltd: Change of Director's Interest Notice
Mayne Pharma Group Ltd: Notification regarding unquoted securities - MYX
Mayne Pharma Group Ltd: Notification of cessation of securities - MYX
Mayne Pharma Group Ltd: Civil action against Mayne Pharma discontinued in Canada
Mayne Pharma Group Ltd: Notification of cessation of securities - MYX
Mayne Pharma Group Ltd: 2024 Full Year Results Investor Presentation
Mayne Pharma Group Ltd: 2024 Full Year Results Media Release
Mayne Pharma Group Ltd: Appendix 4E and Full Year Statutory Accounts
Mayne Pharma Group Ltd: Notification of date for release of FY24 results
Mayne Pharma Group Ltd: MYX announces patent lawsuit against Sun Pharmaceutical
Mayne Pharma Group Ltd: Class action settlement
Mayne Pharma Group Ltd: MYX presentation at Jefferies Global Healthcare Conference
Mayne Pharma Group Ltd: Approval of additional KAPANOL dosages in Switzerland
Mayne Pharma Group Ltd: MYX to present at Jefferies Global Healthcare Conference
Mayne Pharma Group Ltd: Notification of buy-back - MYX
Mayne Pharma Group Ltd: Update - Notification of buy-back - MYX
Mayne Pharma Group Ltd: Mayne Pharma Market Update
Mayne Pharma Group Ltd: Notification of cessation of securities - MYX
Mayne Pharma Group Ltd: MYX presentation at Citizens JMP Life Sciences Conference
No Data